Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
SEATTLE, Sept. 1 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that management will present at the following investor conferences in September.
The following presentations will be webcast:
Rodman & Renshaw 12th Annual Health Care Conference, New York, NY |
|
September 13, 2010 |
|
9:35 a.m. ET |
|
Morgan Stanley 2010 Global Health Care Conference, New York, NY |
|
September 13, 2010 |
|
2:10 p.m. ET |
|
Baird's 2010 Health Care Conference, New York, NY |
|
September 15, 2010 |
|
1:45 p.m. ET |
|
Bank of America Merrill Lynch 2010 Global Health Care Conference, London, UK |
|
September 16, 2010 |
|
6:20 a.m. ET |
|
The presentations will be audio webcast live and available for replay from Dendreon's website, www.dendreon.com.
Dendreon Corporation is a biotechnology company targeting cancer and transforming lives through the discovery, development, commercialization and manufacturing of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response in a variety of tumor types. Dendreon's first autologous cellular immunotherapy product, PROVENGE® (sipuleucel-T), was approved by the FDA in April 2010 for the treatment of asymptomatic or minimally symptomatic metastatic, castrate-resistant (hormone-refractory) prostate cancer. Dendreon also is developing an orally-available small molecule that targets TRPM8 that could be applicable to multiple types of cancer. The Company is headquartered in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit www.dendreon.com
SOURCE Dendreon Corporation
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article